Equity-Based Compensation (Tables)
|
6 Months Ended |
Jun. 30, 2025 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Stock Option Activity Transactions |
The following is a summary of the stock option transactions as of and for the three and six months ended June 30, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | Stock Options Outstanding | | (amounts in thousands, except shares and per share amount) | Shares Subject to Options Outstanding | | Weighted- Average Exercise Price per Option | | Weighted- Average Remaining Contractual Terms (in years) | | Aggregate Intrinsic Value | | Balances as of December 31, 2024 | 8,762,481 | | $ | 16.97 | | | 6.29 | | $ | 2,250 | | | Options granted | — | | — | | | | | | | Options exercised | (24,472) | | 8.47 | | | | | | | Options forfeited / expired | (20,516) | | 16.06 | | | | | | | Balances as of March 31, 2025 | 8,717,493 | | 17.00 | | | 6.04 | | 14,203 | | | Options granted | — | | | | | | | | Options exercised | (99,107) | | 16.30 | | | | | | | Options forfeited / expired | (113,097) | | 16.22 | | | | | | | Balances as of June 30, 2025 | 8,505,289 | | 17.02 | | | 5.78 | | 4,624 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Vested and Exercisable as of June 30, 2025 | 8,044,833 | | $ | 17.65 | | | 5.76 | | $ | 3,427 | |
|
| Schedule of Restricted Stock Transactions |
The following is a summary of RSU transactions as of and for the three and six months ended June 30, 2025: | | | | | | | | | | | | | | Restricted Stock Units | | Weighted-Average Grant Date Fair Value | | Unvested and outstanding as of December 31, 2024 | 13,344,685 | | $ | 9.05 | | | Granted | 2,214,287 | | 15.48 | Vested(1) | (3,004,707) | | 6.74 | | Forfeited | (321,137) | | 8.71 | | Unvested and outstanding as of March 31, 2025 | 12,233,128 | | $ | 10.79 | | | Granted | 548,878 | | 15.49 | Vested(1) | (132,858) | | 8.55 | | Cancelled/forfeited | (561,412) | | 9.56 | | Unvested and outstanding as of June 30, 2025 | 12,087,736 | | $ | 11.08 | | | | | | | | | | | | | | | | | |
(1) Includes shares that vested but the issuance and delivery of the shares was deferred.
|
| Schedule of PSUs Transactions |
The following is a summary of PSU transactions for the three and six months ended June 30, 2025: | | | | | | | | | | | | | | Performance-based restricted stock units | | Weighted-Average Grant Date Fair Value | | Unvested and outstanding as of December 31, 2024 | 8,074,871 | | $ | 5.64 | | | Granted | 714,193 | | 15.50 | | | Vested | (3,826,723) | | 5.74 | | | Forfeited | (8,334) | | 5.74 | | | Unvested and outstanding as of March 31, 2025 | 4,954,007 | | $ | 6.98 | | | Granted | 81,593 | | 15.32 | | | Vested | (9,734) | | 5.74 | | | Cancelled/forfeited | (500,634) | | 7.44 | | | Unvested and outstanding as of June 30, 2025 | 4,525,232 | | $ | 7.09 | | | | | | | | | | | | | | | | | |
|
| Schedule of Equity-Based Compensation Expense of Operation |
Total equity-based compensation expense was presented on the statement of operations as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | (amounts in thousands) | 2025 | | 2024 | | 2025 | | 2024 | | Selling, general and administrative expenses | $ | 13,959 | | | $ | 16,022 | | | $ | 29,994 | | | $ | 35,743 | | | Medical expenses | 1,594 | | | 762 | | | 2,746 | | | 1,895 | | | Total equity-based compensation expense | $ | 15,553 | | | $ | 16,784 | | | $ | 32,740 | | | $ | 37,638 | |
|